Abnormal Glucagon Secretion in Type 2 (Noninsulin-Dependent) Diabetes Mellitus: Causes and Consequences

  • J. E. Gerich
Part of the Bayer AG Centenary Symposium book series (BAYER)

Abstract

Insulin and glucagon are generally acknowledged to be the most important hormones responsible for the moment-to-moment control of plasma glucose concentrations in man [41]. This is due to their immediate antagonistic effects on the liver; insulin suppresses hepatic glucose output and glucagon stimulates hepatic glucose output. Moreover, secretion of these hormones is reciprocally regulated by glucose; an increase in arterial glucose stimulates insulin secretion and suppresses glucagon secretion, whereas a decrease in arterial glucose suppresses insulin secretion and stimulates glucagon secretion [15].

Keywords

Obesity Carbohydrate Arginine Hyperglycemia Glucagon 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aydin I, Raskin P, Unger R (1977) The effects of short-term intravenous insulin administration on the glucagon response to a carbohydrate meal in adult onset and juvenile-type diabetes. Diabetologia 13: 629–636PubMedCrossRefGoogle Scholar
  2. 2.
    Baron AR, Schaeffer L, Shragg P, Kolterman OG (1987) Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type 2 diabetes. Diabetes 36: 274–283PubMedCrossRefGoogle Scholar
  3. 3.
    Best J, Judzewitsch R, Pfeifer M, Beard J, Halter J, Porte D (1982) The effect of chronic sulfonylurea therapy on hepatic glucose production in noninsulin-dependent diabetes. Diabetes 31: 333–338PubMedCrossRefGoogle Scholar
  4. 4.
    Bolli G, Tsalikian E, Haymond M, Cryer P, Gerich J (1984) Defective glucose counterregulation after subcutaneous insulin in NIDDM. J Clin Invest 73: 1532–1541PubMedCrossRefGoogle Scholar
  5. 5.
    Campbell P, Mandarino L, Gerich J (1988) Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in noninsulin-dependent diabetes mellitus. Metabolism 37: 15–22PubMedCrossRefGoogle Scholar
  6. 6.
    Chiles R, Tzagournis M (1970) Excessive serum insulin response to oral glucose in obesity and mild diabetes. Diabetes 19: 458–464PubMedGoogle Scholar
  7. 7.
    Consoli A, Nurjhan N, Kennedy F, Gerich J (1987) Accelerated gluconeogenesis accounts for all of the increase in basal hepatic glucose output of noninsulin-dependent diabetes mellitus. Diabetes 36 [Supl 1]: 4AGoogle Scholar
  8. 8.
    Day J, Anderson J (1973) Abnormalities of glucagon metabolism in diabetes mellitus. Clin Endocrinol 2: 211–217CrossRefGoogle Scholar
  9. 9.
    De Fronzo R, Ferrannini E, Kovisto V (1983) New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus. Am J Med [Suppl IA] 74: 52–81CrossRefGoogle Scholar
  10. 10.
    Delia Porta P, Maiola A, Negri V, Rossella E (1964) Cerebral blood flow and metabolism in therapeutic insulin coma. Metabolism 13: 131–140CrossRefGoogle Scholar
  11. 11.
    Dimitriadis G, Cryer P, Gerich J (1985) Prolonged hyperglycemia during infusion of glucose and somatostatin impairs pancreatic A- and B-cell responses to decrements in plasma glucose in normal man: evidence for induction of altered sensitivity to glucose. Diabetologia 28: 63–69PubMedGoogle Scholar
  12. 12.
    Dimitriadis G, Pehling G, Gerich J (1985) Abnormal glucose modulation of islet A- and B-cell responses to arginine in NIDDM. Diabetes 34: 541–547PubMedCrossRefGoogle Scholar
  13. 13.
    Ferrannini E, Simonson D, Katz L, Reichard G, Bevilacqua S, Barrett E, Olsson M, De Fronzo R (1988) The disposal of an oral glucose load in patients with noninsulin-dependent diabetes. Metabolism 37: 79–85PubMedCrossRefGoogle Scholar
  14. 14.
    Fujita Y, Herron A, Seltzer H (1975) Confirmation of impaired early insulin response to glycemic stimulus in nonobese mild diabetes. Diabetes 24: 17–28PubMedCrossRefGoogle Scholar
  15. 15.
    Gerich J, Charles M, Grodsky G (1976) Regulation of pancreatic insulin and glucagon secretion. Ann Rev Physiol 38: 353–388CrossRefGoogle Scholar
  16. 16.
    Gerich J, Lorenzi M, Karam J, Schneider V, Forsham P (1975) Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus. JAMA 234: 159–165PubMedCrossRefGoogle Scholar
  17. 17.
    Gerich J, Lorenzi M, Schneider V, Karam J, Rivier J, Guillemin R, Forsham P (1974) Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus: pathophysiologic and therapeutic implications. N Engl J Med 291: 544–547PubMedCrossRefGoogle Scholar
  18. 18.
    Halter J, Ward W, Porte D, Best J, Pfeiffer M (1985) Glucose regulation in NIDDM: interaction between pancreatic islets and the liver. Am J Med [Suppl 2B]: 6–12Google Scholar
  19. 19.
    Hollander P, Asplin C, Palmer J (1982) Glucose modulation of insulin and glucagon secretion in nondiabetic and diabetic man. Diabetes 31: 489–495PubMedCrossRefGoogle Scholar
  20. 20.
    Jaspan J, Rubenstein A (1977) Circulating glucagon: plasma profiles and metabolism in health and disease. Diabetes 26: 887–902PubMedGoogle Scholar
  21. 21.
    Kawamori R, Schichiri M, KikuchiM, Yamasaki Y, Abe H (1980) Perfect normalization of excessive glucagon responses to intravenous arginine in human diabetes mellitus with the artificial beta-cell. Diabetes 29: 762–765Google Scholar
  22. 22.
    Kelley D, Mitrakou A, Marsh H, Schwenk F, Benn J, Sonnenberg G, Archangeli M, Aoki T, Sorenson T, Berger M, Sonksen P, Gerich J (1988) The metabolic fate of orally administered glucose in normal human volunteers. J Clin Invest 51: 1563–1571CrossRefGoogle Scholar
  23. 23.
    Kipnis D (1969) Insulin secretion in diabetes mellitus. Ann Int Med 69: 891–901Google Scholar
  24. 24.
    Leahy J, Copper H, Deal D, Weir G (1986) Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions. J Clin Invest 77: 908–915Google Scholar
  25. 25.
    Nonaka K. Toyoshima H, Hanafusa T, Tarui S (1980) Parallel dysfunctions of pancreatic A, B, and PP cells in insulin-dependent diabetes. Endocrinol Jpn 1: 127–133CrossRefGoogle Scholar
  26. 26.
    Ohneda A, Ishu S, Horigome K., Yomogata S (1975) Glucagon response to arginine after treatment of diabetes mellitus. Diabetes 24: 811–819PubMedCrossRefGoogle Scholar
  27. 27.
    O’Rahilly S, Rudenski A, Burnett M, Nugent Z, Hosket J, Darling P, Turner R (1986) Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type II diabetes. Lancet II: 360–364Google Scholar
  28. 28.
    Palmer J, Benson J, Walter R, Ensinck J (1976) Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects. J Clin Invest 58: 565–570PubMedCrossRefGoogle Scholar
  29. 29.
    Rahier J, Goebbels R, Henquin J (1983) Cellular composition of the human diabetic pancreas. Diabetologia 24: 366–371PubMedCrossRefGoogle Scholar
  30. 30.
    Raskin P, Aydin I, Unger R (1976) Effects of insulin on the exaggerated glucagon response to arginine stimulation in diabetes mellitus. Diabetes 25: 227–229PubMedCrossRefGoogle Scholar
  31. 31.
    Raskin P, Aydin I, Yamamoto T, Unger R (1978) Abnormal alpha-cell function in diabetes: the response to oral protein. Am J Med 64: 988–997PubMedCrossRefGoogle Scholar
  32. 32.
    Raskin P, Fujita Y, Unger R (1975) Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics. J Clin Invest 56: 1132–1138PubMedCrossRefGoogle Scholar
  33. 33.
    Raskin P, Unger R (1978) Effects of insulin therapy on the profiles of plasma immunoreactive glucagon in juvenile-type and adult-type diabetes. Diabetes 27: 411–419PubMedGoogle Scholar
  34. 34.
    Reaven G, Berstein R, Davis B, Olefsky J (1976) Nonketotic diabetes mellitus: insulin deficiency or insulin resistance. Am J Med 60: 80–88PubMedCrossRefGoogle Scholar
  35. 35.
    Rizza R, Mandarino L, Gerich J (1981) Mechanism and significance of insulin resistance in noninsulin-dependent diabetes mellitus. Diabetes 30: 990–995PubMedCrossRefGoogle Scholar
  36. 36.
    Rizza R, Verdonk C, Miles J, Service F, Gerich J (1979) Effects of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man. J Clin Invest 63: 1119–1123PubMedCrossRefGoogle Scholar
  37. 37.
    Savage P, Benncon L, Bennett P (1979) Normalization of insulin and glucagon secretion in ketosis-resistant diabetes mellitus with prolonged diet therapy. J Clin Endocrinol Metab 49: 830–833PubMedCrossRefGoogle Scholar
  38. 38.
    Schulz B, Ziegler M, Wilt S, Rjasanowski I, Heinke P, Bibergerl H (1978) Regulation of pancreatic glucagon secretion during a continuous glucose infusion in early and overt diabetes. Acta Endocrinol 89: 329–338PubMedGoogle Scholar
  39. 39.
    Shichiri M, Kawamori R, Abe H (1979) Normalization of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell. Diabetes 28: 272–275PubMedCrossRefGoogle Scholar
  40. 40.
    Stevenson RW, Williams PE, Cherrington AD (1987) Role of glucagon suppression on gluconeogenesis during insulin treatment of the conscious dog. Diabetologia 30: 782–790PubMedCrossRefGoogle Scholar
  41. 41.
    Unger R (1978) Role of glucagon in the pathogenesis of diabetes: the status of the controversy. Metabolism 27: 1691–1709PubMedCrossRefGoogle Scholar
  42. 42.
    Unger R, Agiular-Parada E, Muller W, Eisentraut A (1970) Studies of pancreatic alpha-cell function in normal and diabetic subjects. J Clin Invest 49: 837–848PubMedCrossRefGoogle Scholar
  43. 43.
    Unger R, Madison L, Miller W (1972) Abnormal alpha-cell function in diabetes: response to insulin. Diabetes 21: 301–309Google Scholar
  44. 44.
    Yamamoto T, Raskin P, Aydin I, Unger R (1979) Effects of insulin on the response of immunoreactive glucagon to an intravenous glucose load in human diabetes. Metabolism 28: 568–574PubMedCrossRefGoogle Scholar
  45. 45.
    Seino Y, Ikeda M, Kurachi H, Taminato T, Sakurai H, Goto Y, Inoue Y, Seizo K, Mori K, Imura H (1978). Failure to suppress plasma glucagon concentrations by orally administered glucose in diabetic patients after treatment. Diabetes 27: 1145–1150PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • J. E. Gerich

There are no affiliations available

Personalised recommendations